China Independent Clinical Laboratory Market Outlook to 2018

The report titled "China Independent Clinical Laboratory Market Outlook to 2018 - Escalating Significance of Diagnostic Tests to Impel Growth" provides a comprehensive analysis of the market size of the Independent Clinical Labs Industry in China. Industry has been segmented on the basis of services offered by the labs and expenditure incurred on the equipments. The report also entails the market share and company profiles of the major players in the China Independent Clinical Laboratory industry. An analysis of the future of Independent Clinical Laboratory market in China is provided on the basis of revenue of the market over next five years.

The China independent clinical laboratory market revenue by services has grown at a CAGR of 45.0% which has increased from USD ~ million in 2008 to USD ~ million in 2013. Increasing incidences of lifestyle diseases, mounting health awareness, growing consolidations and strategic partnership, accreditation of laboratories, rapid urbanization, increasing number of laboratories and the overall improvement in the medical infrastructure are some of the major factors responsible for the growth of independent clinical labs market showcased over the last 6 years.

Market growth was primarily led by the immunology, biochemistry and hematology segments. The highest contribution to the revenues was contributed by the immunology market, followed by the revenues from the biochemistry market.

The versatility of diseases and the increasing frequency of diagnostic tests have driven the market of independent clinical laboratory equipments in China. The expenditure incurred by nearly 8000 anatomical labs in China on equipments has grown at the CAGR of 25.1%; having increased from USD ~ million in 2008 to USD ~million in 2013. With the growth of health care technology, the expenditure incurred by the laboratories on equipments has continued to grow over the past 5 years.

Independent clinical laboratory equipments include Cervical cytology, Pre-staining histology, Microscopy and Routine/IHC staining. Cervical cytology accounted for the majority share of ~% in total independent lab expenditure on equipments in 2013 followed by Pre-staining histology with ~% share in the same year.

Independent clinical laboratory industry in China is poised to grow gradually and steadily in the coming 5 years. Its steady growth will be driven by an extensive consumer base. Streamlined distribution network has made diagnostic services easily accessible in various regions. An increase in the number of pathology laboratories and inclining number of hospitals, both in the public and the private sector will result in the enhancement of the overall healthcare infrastructure. Consequently, easier accessibility of healthcare will provide a significant thrust to the diagnostic service market in China. . It is anticipated that the independent clinical laboratory revenue will reach USD 3,369.2 million by 2018 by growing at a CAGR of 45.9% during the period 2013-2018.

KEY TOPICS COVERED IN THE REPORT

- The market size of the China Independent Clinical Labs Industry on the basis of Revenue Earned through Services, 2008-2013

- The market size of the China Independent Clinical Labs Industry on the basis of Expenditure Incurred on Equipments, 2008-2013

- Market segmentation of China Independent Clinical Labs Industry by services

- Market segmentation of China Independent Clinical Labs Industry by expenditure on equipments, 2008-2013

- Growth Drivers for the China Independent Clinical Labs Industry

- Recent Industry Activities in China Independent Clinical Labs Industry

- Market Share of Major Players in China Independent Clinical Labs Industry

- Company profiles of major players in the China Independent Clinical Labs Industry

- Future outlook and projections on the basis of revenue in China Independent Clinical Labs Industry, 2014-2018